兴科蓉医药(06833)发布中期业绩,股东应占收益1990.9万元 同比减少18.37%

智通财经
Aug 28

智通财经APP讯,兴科蓉医药(06833)发布截至2026年6月30日止6个月中期业绩,该集团取得收益10.32亿元,同比减少13.66%;公司拥有人应占收益1990.9万元,同比减少18.37%;每股盈利0.0098元。

随着本集团收益减少,报告期内,本集团毛利减少660万元至1.24亿元(截至2025年6月30日止6个月:1.307亿元),而毛利率由10.9%上升至12.0%,乃由于采购成本下降及人民币兑美元升值,令销售成本减少所致。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10